Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Perfusion Tech ApS
APS
Active
Advertising protection
CVR 38238213
Viborggade 70D, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
10 employees
perfusiontech.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Perfusion Tech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
DC
Declan Cassells
Management
Management
2025
Former (2)
MA
Mads Aagaard Linde Madsen
Chief Executive Officer
Chief Executive Officer
2016 – 2023
PC
Pernille Charlotte Singer
Chief Executive Officer
Chief Executive Officer
2023 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Former (7)
LH
Lars Henning Stigel
Board of Directors
Board of Directors
2020 – 2023
SS
Sten Scheibye
Board of Directors
Board of Directors
2022 – 2025
HC
Henrik Christensen
Chairman
Chairman
2023 – 2025
JØ
Jeppe Øvli Øvlesen
Board of Directors
Board of Directors
2017 – 2025
SB
Steffen Boutrup Møller
Board of Directors
Board of Directors
2017 – 2020
TE
Thomas Engelbrecht Nordkild Jonassen
Board of Directors
Board of Directors
2017 – 2025
MA
Morten Asp Vonsild Lund
Chairman
Chairman
2017 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Renew Pharmaceuticals Limited
Individual
100%
100%
2025
TJ Biotech Holding ApS
Company
5–9.99%
5–9.99%
2023
Uddannelses- og Forskningsstyrelsen
Company
5–9.99%
5–9.99%
2023
ASBA CONSULTING ApS
Company
15–19.99%
15–19.99%
2016
TJ BIOTECH HOLDING ApS
Company
10–14.99%
10–14.99%
2019
Quantass ApS
Company
5–9.99%
5–9.99%
2024
QUANTASS ApS
Company
10–14.99%
10–14.99%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Perfusion Tech ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network